CX 4945: Clinical Trials

1 trial of CX 4945, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow CX 4945: new trials by email Literature Review of CX 4945 trials Research Report on CX 4945

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery
CX 4945 - Medulloblastoma, Childhood, Medulloblastoma Recurrent
Phase 1 / Phase 2TerminatedPediatric Brain Tumor Consortium212019-07-252026-10-19

Conditions studied

Medulloblastoma (1)  ·  Microphthalmia, Isolated, with Coloboma 5 (1)

Sponsors

Pediatric Brain Tumor Consortium (1)

Countries

United States (1)

Top investigators

Ralph Salloum, MD (1)

NIH funding

UM1CA081457 (1)